SB 570 — An Act amending Title 20 (Decedents, Estates and Fiduciaries) of the Pennsylvania Consolidated Statutes, providing for End of Life Options Act; imposing duties on the Department of Health; and imposing penalties.
Congress · introduced 2025-04-11
Latest action: — Referred to JUDICIARY, April 11, 2025
Sponsors
- Lisa M. Boscola (D, PA-18) — sponsor · 2025-04-11
- Sharif Street (D, PA-3) — cosponsor · 2025-04-11
- Wayne D. Fontana (D, PA-42) — cosponsor · 2025-04-11
- Timothy P. Kearney (D, PA-26) — cosponsor · 2025-04-11
- Carolyn T. Comitta (D, PA-19) — cosponsor · 2025-04-11
- Amanda M. Cappelletti (D, PA-17) — cosponsor · 2025-04-11
Action timeline
- · senate — Referred to JUDICIARY, April 11, 2025
Text versions
No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.
Bill text
Printer's No. 0638 · 35,846 characters · source document
Read the full text
PRINTER'S NO. 638
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No. 570
Session of
2025
INTRODUCED BY BOSCOLA, STREET, FONTANA AND KEARNEY,
APRIL 11, 2025
REFERRED TO JUDICIARY, APRIL 11, 2025
AN ACT
1 Amending Title 20 (Decedents, Estates and Fiduciaries) of the
2 Pennsylvania Consolidated Statutes, providing for End of Life
3 Options Act; imposing duties on the Department of Health; and
4 imposing penalties.
5 The General Assembly of the Commonwealth of Pennsylvania
6 hereby enacts as follows:
7 Section 1. Title 20 of the Pennsylvania Consolidated
8 Statutes is amended by adding a chapter to read:
9 CHAPTER 54B
10 END OF LIFE OPTIONS ACT
11 Sec.
12 54B01. Definitions.
13 54B02. Qualified patient requirements.
14 54B03. Request for medication.
15 54B04. Right and opportunity to rescind request.
16 54B05. Form of written request.
17 54B06. Waiting periods.
18 54B07. Attending provider responsibilities.
19 54B08. Confirmation of terminal illness.
1 54B09. Counseling referral.
2 54B10. Family notification.
3 54B11. Medical record documentation requirements.
4 54B12. Reporting requirements.
5 54B13. Effect on construction of wills and contracts.
6 54B14. Insurance or annuity policies.
7 54B15. Disposal of unused medication.
8 54B16. Health care provider participation, notification and
9 permissible sanctions.
10 54B17. Claims by governmental entity for costs incurred.
11 54B18. Construction.
12 54B19. Immunity.
13 54B20. Liability.
14 54B21. Prohibitions and penalties.
15 § 54B01. Definitions.
16 The following words and phrases when used in this chapter
17 shall have the meanings given to them in this section unless the
18 context clearly indicates otherwise:
19 "Attending provider." The provider who has primary
20 responsibility for the care of a patient with a terminal illness
21 and treatment of the patient's terminal illness.
22 "Capable." The ability of a patient to make and communicate
23 informed health care decisions without impaired judgment to
24 health care providers, including communication through
25 individuals familiar with the patient's manner of communicating,
26 as determined by a court or a patient's attending provider,
27 consulting provider, mental health care professional or clinical
28 social worker.
29 "Confirmation of terminal illness." A written confirmation
30 from a consulting provider of a patient's terminal illness.
20250SB0570PN0638 - 2 -
1 "Consulting provider." A provider who is qualified by
2 specialty or experience to make a professional diagnosis and
3 prognosis regarding a patient's terminal illness.
4 "Counseling." One or more consultations between a mental
5 health care provider and a patient for the purpose of
6 determining if the patient is capable.
7 "Department." The Department of Health of the Commonwealth.
8 "End-of-life medication." A medication determined and
9 prescribed by an attending provider to a qualified patient,
10 which the qualified patient may administer to end the qualified
11 patient's life.
12 "Health care facility." A health care facility as defined in
13 section 802.1 of the act of July 19, 1979 (P.L.130, No.48),
14 known as the Health Care Facilities Act.
15 "Health care provider." A person licensed, certified or
16 otherwise authorized or permitted by the laws of this
17 Commonwealth to administer health care services or dispense
18 medication in the ordinary course of business or practice of a
19 profession.
20 "Informed decision." A decision by a patient to request and
21 obtain a prescription for end-of-life medication which is based
22 on an appreciation of the relevant facts after being fully
23 informed by the attending provider of the information required
24 under section 54B07 (relating to attending provider
25 responsibilities).
26 "Long-term care facility." A long-term care nursing facility
27 as defined in section 802.1 of the Health Care Facilities Act.
28 "Medical confirmation." The confirmation by a consulting
29 provider who has examined the patient and the patient's relevant
30 medical records that the patient has a terminal illness, is
20250SB0570PN0638 - 3 -
1 capable and is voluntarily making an informed decision.
2 "Mental health care provider." A person who is licensed,
3 certified or otherwise authorized by the laws of this
4 Commonwealth to administer or provide mental health care in the
5 ordinary course of business or practice of a profession.
6 "Participate under this chapter." To perform the duties of
7 an attending provider under section 54B07, the consulting
8 provider function under section 54B08 (relating to confirmation
9 of terminal illness) or the consultation function under section
10 54B09 (relating to counseling referral). The term does not
11 include:
12 (1) making an initial determination that a patient has a
13 terminal illness and informing the patient of the medical
14 prognosis;
15 (2) providing information about end-of-life medication
16 and related information to a patient upon request;
17 (3) providing, upon the request of the patient, a
18 referral to another provider; or
19 (4) contracting by a patient with the patient's
20 attending provider and consulting provider to act outside of
21 the course and scope of the health care provider's capacity
22 as an employee or independent contractor of the sanctioning
23 health care provider.
24 "Patient." An individual who is:
25 (1) eighteen years of age or older; and
26 (2) under the care of an attending provider.
27 "Provider." The following:
28 (1) A doctor of medicine or osteopathy licensed to
29 practice by the State Board of Medicine or State Board of
30 Osteopathic Medicine.
20250SB0570PN0638 - 4 -
1 (2) An advanced practice registered nurse practitioner
2 licensed to practice by the State Board of Nursing.
3 "Qualified patient." A patient who meets the requirements of
4 section 54B02 (relating to qualified patient requirements).
5 "Terminal illness." An incurable and irreversible illness
6 that will, within reasonable medical judgment, produce death
7 within six months.
8 § 54B02. Qualified patient requirements.
9 To qualify to receive end-of-life medication under this
10 chapter, a patient must:
11 (1) Have a terminal illness, as determined by an
12 attending provider and a consulting provider.
13 (2) Be capable of making an informed decision, as
14 determined under sections 54B07 (relating to attending
15 provider responsibilities) and 54B08(3) (relating to
16 confirmation of terminal illness).
17 (3) Be a resident of this Commonwealth.
18 § 54B03. Request for medication.
19 (a) Patient request.--A qualified patient may make a request
20 under subsection (b) for end-of-life medication for the purpose
21 of ending the qualified patient's life in a compassionate,
22 humane and dignified manner under this chapter.
23 (b) Request requirements.--In order to receive a
24 prescription for end-of-life medication, a qualified patient
25 must:
26 (1) Make an oral request to the attending provider.
27 (2) Except as provided for under section 54B06 (relating
28 to waiting periods), reiterate the oral request by making a
29 second oral request to the attending provider no less than 15
30 days after making the initial oral request.
20250SB0570PN0638 - 5 -
1 (3) Make a written request to the attending provider in
2 the form required under section 54B05 (relating to form of
3 written request).
4 (c) Requester.--Oral and written requests for medication
5 under this chapter must be made by a qualified patient and may
6 not be made by any other individual, including a terminally ill
7 individual's qualified power of attorney, attorney-in-fact for
8 health care or via advance health care directive.
9 § 54B04. Right and opportunity to rescind request.
10 (a) Rescission.--A qualified patient may rescind the request
11 to end the qualified patient's life at any time and in any
12 manner without regard to mental state.
13 (b) Opportunity required.--At the time a qualified patient
14 makes the qualified patient's second oral request, the attending
15 provider must offer the qualified patient an opportunity to
16 rescind the request.
17 (c) Prohibition.--A prescription for end-of-life medication
18 under this chapter may not be written without the attending
19 provider offering the qualified patient an opportunity to
20 rescind the request.
21 § 54B05. Form of written request.
22 (a) Signature, date and attestation.--A valid request for
23 end-of-life medication under this chapter shall be in
24 substantially the form under subsection (e), signed and dated by
25 the qualified patient and witnessed by at least two individuals
26 who, in the presence of the qualified patient, attest that to
27 the best of the witness's knowledge and belief the qualified
28 patient is capable, acting voluntarily and not being coerced to
29 sign the request.
30 (b) Witness.--One of the witnesses shall be an individual
20250SB0570PN0638 - 6 -
1 who is not:
2 (1) a relative of the qualified patient by blood,
3 marriage or adoption;
4 (2) someone with whom the qualified patient has had a
5 significant relationship;
6 (3) an individual who, at the time the request is
7 signed, would be entitled to a portion of the estate of the
8 qualified patient upon death under a will or by operation of
9 law; or
10 (4) an owner, operator or employee of a health care
11 facility where the qualified patient is receiving medical
12 treatment or is a resident.
13 (c) Prohibition.--The qualified patient's attending
14 provider, consulting provider or an individual who has conducted
15 an evaluation of the qualified patient at the time the request
16 is signed shall not be a witness.
17 (d) Long-term care patient.--If the qualified patient is in
18 a long-term care facility at the time the written request is
19 made, one of the witnesses shall be an individual designated by
20 the long-term care facility and who has the qualifications
21 required by the department by rule.
22 (e) Form.--A request for end-of-life medication as
23 authorized under this chapter shall be in substantially the
24 following form:
25 REQUEST FOR MEDICATION
26 TO END MY LIFE IN A COMPASSIONATE,
27 HUMANE AND DIGNIFIED MANNER
28 I, , am an adult of sound mind.
29 I am suffering from , which my
30 attending provider has determined is a terminal illness and
20250SB0570PN0638 - 7 -
1 which has been medically confirmed by a consulting provider.
2 I have been fully informed of my diagnosis and prognosis, the
3 nature of medication to be prescribed and potential associated
4 risks, the expected result and the feasible alternatives,
5 including comfort care, hospice care, palliative care and pain
6 control.
7 I request that my attending provider prescribe medication
8 that will end my life in a compassionate, humane and dignified
9 manner.
10 INITIAL ONE:
11 ( ) I have informed my family or significant other of my
12 decision and have taken their opinions into consideration.
13 ( ) I have decided not to inform my family or
14 significant other of my decision.
15 ( ) I have no family or significant other to inform of
16 my decision.
17 I understand that I have the right to rescind this request at
18 any time.
19 I understand that this request will supersede any provision
20 of an advance directive in conflict with the provisions of this
21 request.
22 I understand the full import of this request and I expect to
23 die when I take the medication to be prescribed. I further
24 understand that although most deaths occur within three hours,
25 my death may take longer and my provider has counseled me about
26 this possibility.
27 I am not being coerced by another individual to make this
28 decision.
29 I make this request voluntarily and without reservation, and
30 I accept full moral responsibility for my actions.
20250SB0570PN0638 - 8 -
1 Signed:
2 Dated:
3 DECLARATION OF WITNESSES
4 We declare that the person signing this request:
5 (a) Is personally known to us or has provided proof of
6 identity.
7 (b) Signed this request in our presence on the date of
8 the person's signature.
9 (c) Appears to be of sound mind and not under duress,
10 fraud or undue influence, such as being coerced by another
11 individual.
12 (d) Is not a patient for whom either of us is an
13 attending provider.
14 Date:
15 Witness' printed name:
16 Witness' signature:
17 Number and Street:
18 City, State and Zip Code:
19 Date:
20 Witness' printed name:
21 Witness' signature:
22 Number and Street:
23 City, State and Zip Code:
24 NOTE: One witness shall not be a relative by blood, marriage
25 or adoption of the person signing this request, shall not be
26 someone with whom the person has a significant relationship,
27 shall not be entitled to any portion of the person's estate upon
28 death and shall not own, operate or be employed at a health care
29 facility where the person is receiving medical treatment or a
30 resident. If the patient is an inpatient at a long-term care
20250SB0570PN0638 - 9 -
1 facility, one of the witnesses shall be a person designated by
2 the facility.
3 § 54B06. Waiting periods.
4 (a) Time frame.--Except as provided under subsection (b),
5 the following apply:
6 (1) At least 15 days shall elapse between the qualified
7 patient's initial oral request and the writing of a
8 prescription for end-of-life medication under this chapter.
9 (2) At least 48 hours shall elapse between the qualified
10 patient's written request and the writing of a prescription
11 for end-of-life medication under this chapter.
12 (b) Exceptions.--
13 (1) If the qualified patient's attending provider has
14 determined, and a medical confirmation is received under
15 section 54B08 (relating to confirmation of terminal illness),
16 that the qualified patient will, within reasonable medical
17 judgment, die within 15 days of making the initial oral
18 request, the qualified patient may reiterate the second oral
19 request to the attending provider at any time after making
20 the initial oral request.
21 (2) If the qualified patient's attending provider has
22 determined, and a medical confirmation is received under
23 section 54B08, that the qualified patient will, within
24 reasonable medical judgment, die before the expiration of at
25 least one of the waiting periods described under subsection
26 (a), the prescription for end-of-life medication under this
27 chapter may be written at any time following the later of the
28 qualified patient's written request or second oral request.
29 § 54B07. Attending provider responsibilities.
30 (a) Responsibilities.--Upon request of a patient, an
20250SB0570PN0638 - 10 -
1 attending provider shall:
2 (1) Determine if the patient has a terminal illness, is
3 capable and has made the request for end-of-life medication
4 voluntarily.
5 (2) Ensure that the patient is making an informed
6 decision and inform the patient of:
7 (i) The patient's medical diagnosis.
8 (ii) The patient's prognosis.
9 (iii) The potential risks associated with taking the
10 end-of-life medication to be prescribed.
11 (iv) The probable result of taking the end-of-life
12 medication to be prescribed.
13 (v) The feasible alternatives, including comfort
14 care, hospice care, palliative care and pain control.
15 (3) Refer the patient to a consulting provider for
16 medical confirmation of the diagnosis and for a determination
17 that the patient is capable and acting voluntarily.
18 (4) Refer the patient for counseling, if appropriate,
19 under section 54B09 (relating to counseling referral).
20 (5) Recommend the patient notify next of kin or someone
21 with whom the patient has a significant relationship.
22 (6) Counsel the patient about the importance of:
23 (i) having another individual present when the
24 patient takes the end-of-life medication prescribed under
25 this chapter; and
26 (ii) not taking the end-of-life medication in a
27 public place.
28 (7) Inform the patient that the patient has an
29 opportunity to rescind the request at any time and in any
30 manner under section 54B04 (relating to right and opportunity
20250SB0570PN0638 - 11 -
1 to rescind request) and offer the patient an opportunity to
2 rescind at the end of the 15-day waiting period or at the
3 time the patient makes the patient's second oral request
4 under section 54B06 (relating to waiting periods).
5 (8) Immediately prior to writing a prescription for end-
6 of-life medication under this chapter, verify the patient is
7 making an informed decision.
8 (9) Fulfill the medical record documentation
9 requirements under section 54B11 (relating to medical record
10 documentation requirements).
11 (10) If the patient fulfills all the requirements under
12 this chapter, approve the qualified patient's request to
13 receive end-of-life medication.
14 (11) (i) Dispense end-of-life medications directly,
15 including ancillary medications intended to facilitate
16 the desired effect to minimize the qualified patient's
17 discomfort if the attending provider is authorized to
18 prescribe medications in this Commonwealth, has a current
19 Drug Enforcement Administration certificate and complies
20 with applicable administrative rules; or
21 (ii) with the qualified patient's written consent:
22 (A) contact a pharmacist and inform the
23 pharmacist of the prescription; and
24 (B) deliver the written prescription personally,
25 electronically, by facsimile or by mail to the
26 pharmacist, who shall dispense the end-of-life
27 medications to the qualified patient, the attending
28 provider or an expressly identified agent of the
29 qualified patient.
30 (b) Death certificate.--The attending provider may sign the
20250SB0570PN0638 - 12 -
1 qualified patient's death certificate.
2 § 54B08. Confirmation of terminal illness.
3 A confirmation of terminal illness must be received before a
4 patient is determined to be a qualified patient under this
5 chapter. The consulting provider performing the confirmation of
6 terminal illness shall physically examine a patient requesting
7 end-of-life medication under section 54B03 (relating to request
8 for medication) and the patient's relevant medical records to
9 confirm the attending provider's diagnosis that the patient is
10 suffering from a terminal illness. The consulting provider must
11 also verify the patient is:
12 (1) Capable.
13 (2) Acting voluntarily.
14 (3) Making an informed decision.
15 § 54B09. Counseling referral.
16 If the opinion of the attending provider or the consulting
17 provider is that the patient may not be capable at the time a
18 written request is made under section 54B03 (relating to request
19 for medication), either the attending provider or consulting
20 provider shall refer the patient to a mental health care
21 provider for counseling. End-of-life medication may not be
22 prescribed until the mental health care provider performing the
23 counseling determines that the patient is capable and able to
24 make a voluntary informed decision without impaired judgment.
25 § 54B10. Family notification.
26 The attending provider must recommend that the qualified
27 patient notify the next of kin or an individual with whom the
28 qualified patient has a significant relationship of the
29 qualified patient's request for end-of-life medication under
30 this chapter. An attending provider may not deny a request for
20250SB0570PN0638 - 13 -
1 end-of-life medication solely because a qualified patient
2 declines or is unable to notify the next of kin or an individual
3 with whom the qualified patient has a significant relationship.
4 § 54B11. Medical record documentation requirements.
5 The following shall be documented or filed in the qualified
6 patient's medical record:
7 (1) All oral requests by a qualified patient for end-of-
8 life medication.
9 (2) All written requests by a qualified patient for end-
10 of-life medication.
11 (3) The attending provider's diagnosis of terminal
12 illness and determination that the qualified patient is
13 capable, acting voluntarily and making an informed decision.
14 (4) All medical confirmations of terminal illness.
15 (5) Documentation that the qualified patient is capable
16 and acting voluntarily and has made an informed decision.
17 (6) A report of the outcome and determinations made
18 during counseling.
19 (7) A certification of the imminence of the qualified
20 patient's death.
21 (8) Documentation of the attending provider's offer to
22 the qualified patient to rescind the qualified patient's
23 request at the time of the qualified patient's second oral
24 request under section 54B03 (relating to request for
25 medication).
26 (9) Documentation by the attending provider that the
27 requirements under this chapter have been met and the steps
28 taken to carry out the request, including a notation of the
29 end-of-life medication prescribed.
30 § 54B12. Reporting requirements.
20250SB0570PN0638 - 14 -
1 (a) Review and rulemaking.--The department shall:
2 (1) Annually review a sample of records maintained under
3 this chapter.
4 (2) Require a health care provider to file a copy of the
5 prescription or the dispensing record with the department
6 upon writing the prescription or dispensing end-of-life
7 medication under this chapter.
8 (3) Promulgate rules to facilitate the collection of
9 information regarding compliance with this chapter.
10 (b) Records.--Except as otherwise provided by law, the
11 information collected is not a public record and may not be made
12 available for inspection by the public.
13 (c) Report.--The department shall generate and make
14 available to the public, to the extent doing so would not be
15 reasonably expected to violate the privacy of any person, an
16 annual statistical report of information collected under
17 subsection (a).
18 § 54B13. Effect on construction of wills and contracts.
19 (a) Effect on existing agreements.--No provision in a
20 contract, will or other agreement, whether written or oral,
21 shall be valid to the extent that the provision would condition
22 or restrict an individual's decision to make or rescind a
23 request for end-of-life medication.
24 (b) Obligations under an existing contract.--No obligation
25 under an existing contract shall be affected by an individual's
26 making or rescinding of a request for end-of-life medication.
27 § 54B14. Insurance or annuity policies.
28 The sale, procurement or issuance of a life, health or
29 accident insurance or annuity policy or the rate charged for a
30 policy shall not be conditioned upon or affected by the making
20250SB0570PN0638 - 15 -
1 or rescinding of a request, by a qualified patient, for end-of-
2 life medication. A qualified patient's act of ingesting end-of-
3 life medication may not have an effect upon a life, health or
4 accident insurance or an annuity policy.
5 § 54B15. Disposal of unused medication.
6 An individual who has custody or control of medication
7 prescribed and dispensed under this chapter that remains unused
8 after the qualified patient's death shall dispose of the
9 medication by lawful means in accordance with Federal and State
10 guidelines.
11 § 54B16. Health care provider participation, notification and
12 permissible sanctions.
13 (a) Participation not required.--No health care provider may
14 be under any duty, whether by contract, statute or other legal
15 requirement, to prescribe or administer end-of-life medication
16 to a qualified patient. If a health care provider is unable or
17 unwilling to carry out a qualified patient's request under this
18 chapter and the qualified patient transfers care to another
19 health care provider, the prior health care provider shall
20 transfer, upon request, a copy of the qualified patient's
21 relevant medical records to the new health care provider.
22 (b) Prohibiting participation.--A health care facility may
23 prohibit a health care provider from participating under this
24 chapter if the prohibiting health care facility has notified the
25 health care provider of the prohibiting health care facility's
26 policy regarding participation under this chapter. Nothing in
27 this subsection prevents a health care provider from providing
28 health care services to a patient that does not constitute
29 participation under this chapter.
30 (c) Notification requirement.--A health care facility shall
20250SB0570PN0638 - 16 -
1 give notice of the policy prohibiting participation under this
2 chapter. A health care facility that fails to provide notice
3 prohibiting participation under this chapter may not enforce
4 sanctions against a health care provider under subsection (d).
5 (d) Sanctions.--Notwithstanding subsection (a) or section
6 54B19 (relating to immunity), a health care facility may subject
7 a health care provider to the sanctions under this subsection if
8 notification was provided as required under subsection (c). The
9 available sanctions shall include:
10 (1) Loss of privileges, loss of membership or other
11 sanctions provided under the medical staff bylaws, policies
12 and procedures if the health care provider is a member of the
13 health care facility's medical staff and participates under
14 this chapter while on the premises, which shall not include
15 the private medical office of a provider or other health care
16 provider.
17 (2) Termination of lease or other property contract or
18 other nonmonetary remedies provided by lease contract, not
19 including loss or restriction of medical staff privileges or
20 exclusion from the health care facility panel, if the health
21 care provider participates under this chapter while on the
22 premises of or on property that is owned by or under the
23 direct control of the health care facility.
24 (3) Termination of contract or other nonmonetary
25 remedies provided by contract if the health care provider
26 participates under this chapter while acting in the course
27 and scope of the health care provider's capacity as an
28 employee or independent contractor of the health care
29 facility. Nothing in this paragraph may be construed to
30 prevent:
20250SB0570PN0638 - 17 -
1 (i) a health care provider from participating under
2 this chapter while acting outside the course and scope of
3 the health care provider's capacity as an employee or
4 independent contractor; or
5 (ii) a patient from contracting with the patient's
6 attending provider and consulting provider to act outside
7 the course and scope of the health care provider's
8 capacity as an employee or independent contractor of the
9 health care facility.
10 (e) Due process.--A health care facility that imposes
11 sanctions under subsection (d) shall follow all due process and
12 other procedures the health care facility may have that are
13 related to the imposition of sanctions on a health care
14 provider.
15 (f) Unprofessional or dishonorable conduct reports.--
16 Authorized action taken under section 54B05 (relating to form of
17 written request), 54B07 (relating to attending provider
18 responsibilities), 54B08 (relating to confirmation of terminal
19 illness) or 54B09 (relating to counseling referral) may not be
20 the sole basis for a report of unprofessional or dishonorable
21 conduct to the State Board of Medicine or the State Board of
22 Osteopathic Medicine.
23 (g) Standard of care.--No provision of this chapter may be
24 construed to allow a lower standard of care for patients in the
25 community where the patient is treated or a similar community.
26 (h) Definitions.--As used in this section, the following
27 words and phrases shall have the meanings given to them in this
28 subsection unless the context clearly indicates otherwise:
29 "Notify." A separate written statement to the health care
30 provider which sanctions its participation in activities covered
20250SB0570PN0638 - 18 -
1 by this chapter before the participation occurs.
2 § 54B17. Claims by governmental entity for costs incurred.
3 A governmental entity that incurs costs resulting from a
4 qualified patient ending the qualified patient's life under this
5 chapter in a public place shall have a claim against the estate
6 of the individual to recover costs and reasonable attorney fees
7 related to enforcing the claim.
8 § 54B18. Construction.
9 Nothing under this chapter may be construed to authorize a
10 provider or any other individual to end a patient's life by
11 lethal injection, mercy killing or active euthanasia. Actions
12 taken in accordance with this chapter shall not constitute
13 suicide, assisted suicide, mercy killing or homicide under the
14 law.
15 § 54B19. Immunity.
16 Except as provided in section 54B20 (relating to liability):
17 (1) An individual may not be subject to civil or
18 criminal liability or professional disciplinary action for
19 participating in good faith compliance with this chapter.
20 This includes being present when a qualified patient takes
21 the prescribed end-of-life medication.
22 (2) A professional organization or association, health
23 care facility or health care provider may not subject an
24 individual to censure, discipline, suspension, loss of
25 license, loss of privileges, loss of membership or other
26 penalty for participating in good faith or refusing to
27 participate under this chapter.
28 (3) A request by a patient for or provision by an
29 attending provider of end-of-life medication in good faith
30 compliance with this chapter does not constitute negligence
20250SB0570PN0638 - 19 -
1 for any purpose of law or provide the sole basis for the
2 appointment of a guardian or conservator.
3 § 54B20. Liability.
4 (a) Mishandling instrument.--An individual who, without
5 authorization of the patient, willfully alters or forges a
6 request for end-of-life medication or conceals or destroys a
7 rescission of that request with the intent or effect of causing
8 the patient's death shall not be immune from criminal liability
9 under section 54B19 (relating to immunity).
10 (b) Undue influence.--An individual, including an attending
11 provider, who coerces or exerts undue influence on a patient to
12 request end-of-life medication for the purpose of ending the
13 patient's life or to destroy a rescission of a request shall not
14 be immune from criminal liability under section 54B19.
15 (c) Civil damages.--Nothing under this chapter limits
16 liability for civil damages resulting from negligent or
17 intentional misconduct or coercion by an individual, including
18 an attending provider.
19 § 54B21. Prohibitions and penalties.
20 (a) Intent to hasten death.--An individual who, without
21 authorization of the patient, willfully alters, forges, conceals
22 or destroys an instrument, the reinstatement or revocation of an
23 instrument or any other evidence or document reflecting the
24 patient's desires and interests with the intent and effect of
25 causing a withholding or withdrawal of life-sustaining
26 procedures or of artificially administered nutrition and
27 hydration which hastens the death of the patient, commits a
28 felony of the first degree.
29 (b) Intent to affect health care decision.--Except as
30 provided in subsection (a), an individual who, without
20250SB0570PN0638 - 20 -
1 authorization of the patient, willfully alters, forges, conceals
2 or destroys an instrument, the reinstatement or revocation of an
3 instrument or any other evidence or document reflecting the
4 patient's desires and interests with the intent or effect of
5 affecting a health care decision, commits a misdemeanor of the
6 first degree.
7 Section 2. This act shall take effect in 120 days.
20250SB0570PN0638 - 21 -Connected on the graph
Outbound (1)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| — | referred_to_committee | Pennsylvania Senate Judiciary Committee | — | pa-leg |
The full graph
Every typed relationship touching this entity — 1 edge across 1 category. Grouped by what the connection is; the heaviest few are shown, with a link to the full list.
Committees
→ Referred to committee 1 edge
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Lisa M. Boscola (D, state_upper PA-18) | sponsor | 0 | — | 5 |
| 2 | Amanda M. Cappelletti (D, state_upper PA-17) | cosponsor | 0 | — | 1 |
| 3 | Carolyn T. Comitta (D, state_upper PA-19) | cosponsor | 0 | — | 1 |
| 4 | Sharif Street (D, state_upper PA-3) | cosponsor | 0 | — | 1 |
| 5 | Timothy P. Kearney (D, state_upper PA-26) | cosponsor | 0 | — | 1 |
| 6 | Wayne D. Fontana (D, state_upper PA-42) | cosponsor | 0 | — | 1 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)
By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-20 · was referred to Pennsylvania Senate Judiciary Committee · pa-leg